Moderna stock is trading up, with reports of it outperforming other vaccine stocks. The extent of the increase is unclear, with varying percentages reported. The stock's movement may be related to impressive cancer vaccine data, although its overall trend is uncertain, with some reports suggesting a recent surge and others warning of a potential downturn.